IL2 and COVID-19: This information illustrates why trying to clarify the contribution of immune cells and mediators such as CD4+ T cells, CD8+ T cells, IL-2, IFN-gamma, and PD-1 to COVID-19 progression is extremely hard in polytreated patients already hospitalized.